| Baxter AG - Endoxan 500 mg, Pulver zur Herstellung einer Infusionslösung |
| 25442 | | 04 | | Endoxan 500 mg | | Pulver zur Herstellung einer Infusionslösung | | L01AA01 | | Cyclophosphamide | | 29.02.1988 | | |
|
| Composition |
| Praeparatio sicca: cyclophosphamidum anhydricum 500 mg ut cyclophosphamidum monohydricum, pro vitro. |
| Packungsbestandteile |
| Dry substance | | | | | | | | Active Agent | Dose | additional_information |
|---|
| Cyclophosphamide Anhydrous | 500 mg correspond Cyclophosphamide Monohydrous | Praeparatio sicca |
| | BAG: Active Agent | Dose |
|---|
| Cyclophosphamide | 500 mg |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 091 | Durchstechflasche(n) | 10.30 | 27.60 | A | SL | No |
|
